The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51–60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry

Documenti analoghi

• A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Severely Underweight Patient with Aplastic Anemia
  di: Lilija Banceviča, et al.
  Pubblicazione: (2024)
• Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response
  di: Zexing Sun, et al.
  Pubblicazione: (2026)
• Case Report: Hematopoietic Stem Cell Transplantation to Treat Severe Acquired Aplastic Anemia in a Pediatric Kidney Transplant Recipient
  di: Gintarė Mierkienė, et al.
  Pubblicazione: (2025)
• Hetrombopag Added to Cyclosporine as the First‐Line Treatment for Patients With Non‐Severe Aplastic Anemia: A Phase 2 Multicenter Trial
  di: Lele Zhang, et al.
  Pubblicazione: (2026)
• Controlling Renal Chronic Graft‐Versus‐Host Disease With a Belumosudil‐Containing Regimen After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
  di: Yimin Wang, et al.
  Pubblicazione: (2025)